Studies show that this might be caused by the overexpression of autotaxin (ATX), especially in aggressive cancers, which leads to decreasing levels of LPCs in plasma and increasing lysophosphatidic acid (LPA) in the tumor microenvironment [37,38]. This evidence concerns the gene ENPP2 and neoplasm.